• IR-1061 Near Infrared Fluorescent Dye Workflow

  2026-08-25

  IR-1061 supports OTN-NIR imaging workflows that prioritize deep-tissue contrast, but its hydrophobicity makes formulation design essential. This guide translates polymer-encapsulation findings into practical preparation, assay, optimization, and troubleshooting decisions for biomedical imaging researchers.

• Protease Inhibitor Cocktail EDTA-Free: K1010 Guide

  2026-08-25

  The Protease Inhibitor Cocktail is a 100X DMSO formulation for limiting endogenous proteolysis during protein extraction. Its EDTA-free design supports workflows that require divalent cations, including phosphorylation analysis and selected kinase assays.

• Olaparib and SmD2: Rethinking HCC PARP Assays

  2026-08-24

  Olaparib and AZD2281 provide a precise way to interrogate PARP-dependent DNA repair in hepatocellular carcinoma. This article explains how SmD2-regulated splicing can refine DNA damage response assays, biomarker interpretation, and combination-study design beyond conventional BRCA-based models.

• Sulfo-NHS-SS-Biotin: Cleavable Labeling Guide

  2026-08-24

  Sulfo-NHS-SS-Biotin provides water-compatible, amine-selective biotinylation for protein capture, detection, and reversible affinity workflows. It is suitable for intact-cell surface labeling and purified protein conjugation, but not for intracellular labeling or assays that require a permanently attached biotin tag.

• ABT-263: From Apoptotic Priming to Translation

  2026-08-23

  ABT-263 (Navitoclax) is more than a cytotoxicity reagent: it is a mechanistic probe for Bcl-2-family dependence, mitochondrial priming, and the selective elimination of chemotherapy-induced senescent cancer cells. This thought-leadership guide connects evidence, assay design, and translational decision-making.

• CHI3L1-IN-5: Astrocyte Aβ Clearance Workflows

  2026-08-22

  CHI3L1-IN-5 (Compound Z17) enables a practical, mechanism-linked workflow for testing inflammatory signaling, astrocyte Aβ uptake, and lysosomal recovery in human cellular models. Its CNS-relevant profiling and selective CHI3L1 mechanism help researchers move beyond single-endpoint neuroinflammation assays.

• EZ Cap™ Cy5 EGFP mRNA: Two-Axis Delivery Assays

  2026-08-22

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables a Cy5-labeled mRNA workflow that separates cellular delivery from functional translation. This article presents a decision framework for interpreting dual fluorescence during nanoparticle validation, macrophage targeting, and quantitative gene-delivery studies.

• gamma-Glu-Cys: Context-First Assay Design

  2026-08-21

  Explore how gamma-Glu-Cys (γ-Glu-Cys) can function as a defined biochemical input for glutathione synthetase enzyme assay design, glutathione metabolism research, and plant stress adaptation studies. This article uses recent Bacillus evidence to explain why medium, strain, and pathway context must be interpreted together.

• Amikacin (BAY416651) for Resistance Workflows

  2026-08-20

  Amikacin (BAY416651) supports mechanism-focused antibiotic resistance research, from reproducible susceptibility testing in resistant Enterobacterales to localized delivery studies in mycobacterial granulomas. This guide pairs practical preparation and assay controls with troubleshooting strategies for solubility, enzyme-mediated resistance, and intracellular localization.

• E-4031: hERG Potassium Channel Blocker Workflow

  2026-08-20

  E-4031 enables controlled hERG/IKr inhibition for cardiac electrophysiology research, from patch-clamp current measurements to QT interval prolongation and proarrhythmic substrate modeling. This guide combines practical assay design, orthogonal validation, and troubleshooting with a methodological lesson from a radiotracer study.

• AZD1390: ATM Inhibition at Replication Stress

  2026-08-19

  AZD1390 is a potent ATM kinase inhibitor for dissecting radiation responses, checkpoint control, and replication-associated genome instability. This article connects ATM perturbation with the REV1–DHX36 pathway that enables tolerance of G-quadruplex DNA, providing a mechanism-led framework for cancer research.

• Propranolol: Designing Better Translational Assays

  2026-08-19

  Propranolol is a non-selective β-adrenergic receptor blocker whose value depends strongly on exposure timing and experimental endpoint. This guide translates emotional memory meta-analysis findings into rigorous assay design while connecting them to cardiovascular regulation, essential tremor therapy, and metabolic research.

• Anagliptin Vasorelaxation: Kv Channels and SERCA

  2026-08-18

  A 2025 Acta Diabetologica study identifies a direct vasorelaxant action of Anagliptin in phenylephrine-contracted rabbit aorta and links the response to voltage-dependent K+ channels and the SERCA pump. The findings extend research on SK-0403 beyond glycemic control while showing that the response was independent of the endothelium and canonical cyclic-nucleotide pathways.

• Protease Inhibitor Cocktail: Protein Workflow Guide

  2026-08-18

  Protect fragile proteins during extraction, Western blotting, co-immunoprecipitation, and cation-sensitive kinase assays with an EDTA-free, broad-spectrum formulation. This guide explains practical dosing, workflow timing, assay-specific advantages, and troubleshooting for the 100X DMSO concentrate.

• CCK-8 Antagonism of Electroacupuncture Analgesia

  2026-08-17

  Han, Ding, and Fan showed that central CCK-8 dose-dependently suppresses electroacupuncture analgesia and that neutralizing endogenous CCK-8 can delay or reverse electroacupuncture tolerance in rats. The study is important because it connects a brain–gut peptide to opioid counter-regulation while distinguishing this effect from baseline nociception and serotonin- or norepinephrine-mediated analgesia.

8534 records 1/569 page Next 12345 下5页 Last page